Sarda Proteins

Market Cap: Small Cap
Industry: Edible Oil
ISIN: INE995U01011
NSEID:
BSEID: 519242

INR

73.93

0.00 (0.00%)

BSENSE

Jan 27

BSE+NSE Vol: 827

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

827 (7,701.89%) Volume

Shareholding (Dec 2025)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

0.00%

Is Sarda Proteins overvalued or undervalued?

09-Jun-2025

As of January 6, 2025, Sarda Proteins Ltd. is considered overvalued with a "risky" rating due to high financial ratios, including a PE Ratio of 22.60 and a Price to Book Value of 9.54, despite a strong 1-year return of 62.51%.

What is the technical trend for Sarda Proteins?

09-Jun-2025

As of May 20, 2025, Sarda Proteins shows a mildly bullish trend with mixed signals from indicators like the MACD, Bollinger Bands, and RSI, suggesting caution despite the current price being at a 52-week high of 137.45.

When is the next results date for Sarda Proteins?

27-Nov-2025

The next results date for Sarda Proteins is 29 November 2025.

How has been the historical performance of Sarda Proteins?

01-Dec-2025

Sarda Proteins has shown significant sales growth, with net sales rising from 1.30 Cr in Mar'24 to 24.19 Cr in Mar'25, but faced challenges with increased expenditures, resulting in marginal operating profit and a decrease in profit after tax and EPS. Overall, while sales and total assets have grown, profitability remains a concern.

Should I buy, sell or hold Sarda Proteins?

02-Dec-2025

Which are the latest news on Sarda Proteins?

03-Dec-2025

How has been the historical performance of Sarda Proteins?
Sarda Proteins Faces Intense Selling Pressure Amidst Consecutive Gains

Why is Sarda Proteins falling/rising?

03-Dec-2025

As of 03-Dec, Sarda Proteins Ltd's stock price is at 80.20, showing no change from the previous session. The stock is underperforming with declining investor participation and significant financial weaknesses, indicating potential downward pressure.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Weak Long Term Fundamental Strength with a -6.89% CAGR growth in Operating Profits over the last 5 years

Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -0.01
The company has been able to generate a Return on Equity (avg) of 3.34% signifying low profitability per unit of shareholders funds

Risky - Negative EBITDA

Below par performance in long term as well as near term

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Edible Oil

Market cap

INR 12 Cr (Small Cap)

P/E

319.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.01

Return on Equity

1.75%

Price to Book

5.33

Revenue and Profits:

Net Sales:

4 Cr

(Quarterly Results - Sep 2025)

Net Profit:

0 Cr

Total Returns

Total Returns (Price + Dividend)

Dividend Yield (0%)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

0.0%

6 Months

0.0%

1 Year

0.0%

2 Years

0.0%

3 Years

58.48%

4 Years

142.79%

5 Years

678.21%

Sarda Proteins for the last several years.

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

How has been the historical performance of Sarda Proteins?

Revenue and Operating Performance Trends

Over the past seven years, Sarda Proteins’ net sales have demonstrated considerable volatility. The company recorded ₹24.19 crores in net sales for the fiscal year ending March 2025, a sharp increase from ₹1.30 crores in the previous year. This surge follows a period of fluctuating sales, with figures ranging between ₹5.40 crores and ₹11.36 crores from 2019 to 2022. The absence of other operating income throughout this period indicates that the company’s revenue is primarily derived from its core operations.

Despite the revenue fluctuations, the company’s total expenditure excluding depreciation closely tracks its operating income, reflecting a tight cost structure. Purchase of finished goods consistently represents the largest ...

Sarda Proteins Faces Intense Selling Pressure Amidst Consecutive Gains

Sarda Proteins Ltd, a key player in the edible oil sector, is currently experiencing extreme selling pressure with only sell orders present in the market queue. Despite a recent streak of gains, the stock’s trading activity today signals distress selling, raising concerns about its near-term outlook.

Sarda Proteins Surges with Unprecedented Buying Interest, Eyes Multi-Day Upper Circuit

Sarda Proteins has witnessed extraordinary buying momentum, with the stock hitting an upper circuit and registering only buy orders in the queue. This rare market phenomenon signals robust investor enthusiasm and raises the prospect of a sustained multi-day circuit scenario, setting it apart from sector peers and broader market trends.

Closure of Trading Window

27-Dec-2025 | Source : BSE

Intimation of Trading Window Closure

Announcement under Regulation 30 (LODR)-Change in Management

08-Dec-2025 | Source : BSE

Intimation of appointment of additional directors of the Company

Board Meeting Outcome for Outcome Of Board Meeting Held On Monday 08-12-2025

08-Dec-2025 | Source : BSE

Outcome of Board Meeting held on 08-12-2025

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

No Dividend history available

SPLITS

No Splits history available

BONUS

No Bonus history available

RIGHTS

No Rights history available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

23.26%

EBIT Growth (5y)

-6.89%

EBIT to Interest (avg)

-0.01

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

0.01

Sales to Capital Employed (avg)

3.34

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

-0.62%

ROE (avg)

3.34%

Valuation key factors

Factor

Value

P/E Ratio

319

Industry P/E

Price to Book Value

5.60

EV to EBIT

-12.79

EV to EBITDA

-12.79

EV to Capital Employed

5.54

EV to Sales

0.83

PEG Ratio

Dividend Yield

ROCE (Latest)

-8.66%

ROE (Latest)

1.75%

Technicals key factors

Indicator

Weekly

Monthly

Technical indicator has not been calculated since the stock has been active for a short period

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2025

Shareholding Compare (%holding)

Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

None

Highest Public shareholder

Guttikonda Vara Lakshmi (3.57%)

Individual Investors Holdings

91.28%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Sep'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is -60.73% vs 0.00% in Jun 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 181.63% vs -345.45% in Jun 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4.30",
          "val2": "10.95",
          "chgp": "-60.73%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.30",
          "val2": "-0.50",
          "chgp": "160.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.40",
          "val2": "-0.49",
          "chgp": "181.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "6.98%",
          "val2": "-4.57%",
          "chgp": "11.55%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is 10,800.00% vs -41.67% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is -400.00% vs 400.00% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "15.26",
          "val2": "0.14",
          "chgp": "10,800.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.19",
          "val2": "0.02",
          "chgp": "-1,050.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.09",
          "val2": "0.03",
          "chgp": "-400.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1.25%",
          "val2": "14.29%",
          "chgp": "-15.54%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Mar 2025 is -88.71% vs -75.49% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Mar 2025 is 0.00% vs 0.00% in Dec 2023",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.14",
          "val2": "1.24",
          "chgp": "-88.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.08",
          "val2": "-0.13",
          "chgp": "38.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.08",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-57.14%",
          "val2": "-10.48%",
          "chgp": "-46.66%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 1,760.77% vs -77.59% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is -50.00% vs 166.67% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "24.19",
          "val2": "1.30",
          "chgp": "1,760.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.02",
          "val2": "-0.14",
          "chgp": "114.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.01",
          "val2": "0.02",
          "chgp": "-50.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.08%",
          "val2": "-10.77%",
          "chgp": "10.85%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Sep'25 - QoQ

Sep'25

Jun'25

Change(%)

Net Sales

4.30

10.95

-60.73%

Operating Profit (PBDIT) excl Other Income

0.30

-0.50

160.00%

Interest

0.00

Exceptional Items

0.00

Standalone Net Profit

0.40

-0.49

181.63%

Operating Profit Margin (Excl OI)

6.98%

-4.57%

11.55%

Values in Rs Cr.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Sep 2025 is -60.73% vs 0.00% in Jun 2025

Standalone Net Profit

QoQ Growth in quarter ended Sep 2025 is 181.63% vs -345.45% in Jun 2025

All Quarterly Results

Half Yearly Results Snapshot (Standalone) - Sep'25

Sep'25

Sep'24

Change(%)

Net Sales

15.26

0.14

10,800.00%

Operating Profit (PBDIT) excl Other Income

-0.19

0.02

-1,050.00%

Interest

0.00

Exceptional Items

0.00

Standalone Net Profit

-0.09

0.03

-400.00%

Operating Profit Margin (Excl OI)

-1.25%

14.29%

-15.54%

Values in Rs Cr.

Compare with Peers

Net Sales

Growth in half year ended Sep 2025 is 10,800.00% vs -41.67% in Sep 2024

Standalone Net Profit

Growth in half year ended Sep 2025 is -400.00% vs 400.00% in Sep 2024

All Half Yearly Results

Nine Monthly Results Snapshot (Standalone) - Mar'25

Mar'25

Dec'23

Change(%)

Net Sales

0.14

1.24

-88.71%

Operating Profit (PBDIT) excl Other Income

-0.08

-0.13

38.46%

Interest

0.00

Exceptional Items

0.00

Standalone Net Profit

-0.08

0.00

Operating Profit Margin (Excl OI)

-57.14%

-10.48%

-46.66%

Values in Rs Cr.

Compare with Peers

Net Sales

YoY Growth in nine months ended Mar 2025 is -88.71% vs -75.49% in Dec 2023

Standalone Net Profit

YoY Growth in nine months ended Mar 2025 is 0.00% vs 0.00% in Dec 2023

All Nine Monthly Results

Annual Results Snapshot (Standalone) - Mar'25

Mar'25

Mar'24

Change(%)

Net Sales

24.19

1.30

1,760.77%

Operating Profit (PBDIT) excl Other Income

0.02

-0.14

114.29%

Interest

0.00

Exceptional Items

0.00

Standalone Net Profit

0.01

0.02

-50.00%

Operating Profit Margin (Excl OI)

0.08%

-10.77%

10.85%

Values in Rs Cr.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2025 is 1,760.77% vs -77.59% in Mar 2024

Standalone Net Profit

YoY Growth in year ended Mar 2025 is -50.00% vs 166.67% in Mar 2024

All Annual Results

Company CV

About Sarda Proteins Ltd

Sarda Proteins Ltd

Small Cap

Edible Oil

Sarda Proteins Ltd was incorporated in December 03, 1991. The company is mainly engaged in the distribution of refined oil, mustard oil and trading of Agro products like wheat, sesame seed, mustard seed, Guar seed and other edible products backed up with strong distribution network.The company had an opening paid up capital as on 1st April 2015 Rs. 2,43,48,500. The company issued a final notice during the year 2015-16 to holders of 16,96,500 partly paid shares of Rs.

Company Coordinates

Company Details

B-536-537, Matsya Industrial Area Alwar Rajasthan : 301030

Tel: 91-144-2881392

http://www.sardaproteins.com

sardaproteins@yahoo.com

Registrar Details

Link Intime India Pvt Ltd., Narang Tower 44, Community Centre, Naraina Industrial Area , Phase - 1, New Delhi

Name: MOJO Markets Private Limited (Research Entity) (SEBI Registration No. INH000021942) (CIN:U74900MH2015PTC264951)

Registered & Correspondence Address: Benefice Business House, Office No. 3B, 3rd Floor, C.S. 242, Mathuradas Mills Estate, N.M. Joshi Marg, Tulsi Pipe Road, Lower Parel West, Mumbai- 400013

For queries or grievances, please contact us on support@mojoinfinity.com, Phone : 022-35121239

"Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors."

Sarda Proteins

1Day

52 Week

CASH

FII

DII

Promoter

Is Sarda Proteins overvalued or undervalued?

What is the technical trend for Sarda Proteins?

When is the next results date for Sarda Proteins?

How has been the historical performance of Sarda Proteins?

Should I buy, sell or hold Sarda Proteins?

Which are the latest news on Sarda Proteins?

Why is Sarda Proteins falling/rising?

Dashboard

Weak Long Term Fundamental Strength with a -6.89% CAGR growth in Operating Profits over the last 5 years

Risky - Negative EBITDA

Below par performance in long term as well as near term

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

Returns Beta

News

How has been the historical performance of Sarda Proteins?

Sarda Proteins Faces Intense Selling Pressure Amidst Consecutive Gains

Sarda Proteins Surges with Unprecedented Buying Interest, Eyes Multi-Day Upper Circuit

Announcements

Closure of Trading Window

Announcement under Regulation 30 (LODR)-Change in Management

Board Meeting Outcome for Outcome Of Board Meeting Held On Monday 08-12-2025

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Dec 2025

Shareholding Compare (%holding)

Quarterly Results Snapshot (Standalone) - Sep'25 - QoQ

Half Yearly Results Snapshot (Standalone) - Sep'25

Nine Monthly Results Snapshot (Standalone) - Mar'25

Annual Results Snapshot (Standalone) - Mar'25

About Sarda Proteins Ltd

Company Coordinates